Illumina's Trading Volume Surges 60.62% to $249 Million, Ranks 349th as Board Shakeup Looms

On March 25, 2025, Illumina's trading volume reached $249 million, marking a 60.62% increase from the previous day, placing it 349th in the day's stock market rankings. Illumina (ILMN) shares fell by 0.56%.

Illumina announced that activist investor Keith Meister would be joining the company's board of directors. This move is part of a broader effort to strengthen the company's leadership and strategic direction. Meister's addition to the board is expected to bring a fresh perspective and potentially drive significant changes within the company.

In addition to Meister, Scott Gottlieb, a former commissioner of the U.S. Food and Drug Administration, has been named as the new chair of Illumina's board. Gottlieb's extensive experience in regulatory affairs and healthcare is anticipated to provide valuable insights and guidance for the company's future endeavors.

These changes to the board are set to take effect on Friday, signaling a new chapter for Illumina as it navigates the competitive landscape of genetic sequencing and related technologies. The company's decision to bring on Meister and elevate Gottlieb reflects its commitment to innovation and strategic growth.